The PROFILE OF ANTIBIOTIC USE IN PATIENTS WITH URINARY TRACT INFECTIONS AT ABDOER RAHEM GENERAL HOSPITAL, SITUBONDO
Abstract
Harmful bacteria multiply, causing urinary tract infections (UTIs). Patients with urinary tract infections often receive antibiotics and supportive care. This study aims to assess the pharmacological treatment of patients with urinary tract infections at RSUD Abdoer Rahem Situbondo. This study used a descriptive design by collecting data retrospectively. This study used a sample of thirty medical records taken using total sampling from May to August 2024. The findings are presented in the form of tables and percentages. The results showed that RSUD Abdoer Rahem Situbondo used urinary tract infection drugs, with 90% of the pharmaceuticals included in the antibiotic class, and cefixime was the most commonly used antibiotic at 27.27%. Ondansetron was the dominant additional treatment, accounting for 21.5% of the total use of additional drugs, followed by ranitidine and lansoprazole at 16.07% and omeprazole and ketorolac at 14.29%.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.